Lamotrigine Desitin

Lamotrigine, the active ingredient in Lamotrigine Desitin, is an Anticonvulsant presented as an oral tablet for oral use. It is approved in the European Union and is prescribed by neurologists and psychiatrists to treat epilepsy and bipolar disorder in adults and children as directed.\n\nGNH India supplies Lamotrigine Desitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to Good Distribution Practice and provides regulatory documentation for importers.

Lamotrigine is an anticonvulsant that stabilizes neuronal activity in seizure‑related and mood‑disorder pathways.\n\n- Epilepsy: reduces the frequency of partial and generalized seizures.\n- Bipolar disorder: helps maintain mood stability and prevents depressive episodes.\n- Lennox‑Gastaut syndrome: used as adjunctive therapy to lessen drop attacks.

Lamotrigine may cause a range of adverse reactions.\n\nCommon Side Effects:\n- Dizziness\n- Headache\n- Nausea\n- Rash\n\nSerious or Rare Side Effects:\n- Stevens‑Johnson syndrome or toxic epidermal necrolysis\n- Severe skin reactions with blistering\n- Blood disorders such as agranulocytosis

When prescribing Lamotrigine, clinicians should consider several safety measures.\n\n- Monitor skin reactions: patients should report any rash promptly.\n- Adjust dose in hepatic impairment: reduce dosage as needed.\n- Avoid abrupt discontinuation: taper under medical supervision.\n- Use caution in patients with cardiac conduction disorders: monitor ECG.\n- Pregnancy and breastfeeding: discuss potential risks with a healthcare provider.\n- Store at ambient temperature: keep in original container, protect from moisture and light.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity.\n\nMajor Interactions (Avoid):\n- Valproic acid: can raise lamotrigine levels, increasing toxicity risk.\n- Carbamazepine: can lower lamotrigine levels, reducing efficacy.\n- Phenobarbital: decreases lamotrigine concentrations.\n- Oral contraceptives: elevate lamotrigine levels, may require dose adjustment.\n\nModerate Interactions (Monitor Closely):\n- Phenytoin: may reduce lamotrigine levels.\n- Serotonergic agents: monitor for signs of serotonin syndrome.\n- SSRIs and other antidepressants: watch for increased side‑effect burden.